CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The product is expected to be launched in Q3FY25
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The inspection concluded with the issuance of a form 483 with five observations
The net-zero target approval complements the company's near-term emission reduction targets
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The company will also share results in two additional posters for deuruxolitinib
Subscribe To Our Newsletter & Stay Updated